Difficulty: Medium
Average Score: 83%
Practice
Selegiline is an antiparkinsonian agent that inhibits which of the following enzymes in brain?
Correct answer
C
Rationale
Selegiline is a selective irreversible inhibitor of the enzyme monoamine oxidase-B (MAO-B). In the brain, MAO-B metabolizes dopamine, which is important in the pathophysiology of Parkinson's disease. By inhibiting MAO-B, selegiline increases dopamine levels in the brain, helping alleviate the symptoms of Parkinson's.
Option A, Catechol-O-methyltransferase (COMT), is not the correct enzyme inhibited by selegiline. COMT is involved in the metabolism of catecholamines outside the brain.
Option B, Tyrosine hydroxylase (TH), is not the correct enzyme inhibited by selegiline. TH is involved in the synthesis of dopamine and is not the target of selegiline action.
Option D, Monoamine oxidase-A (MAO-A), is not the correct enzyme inhibited by selegiline. While MAO-A also plays a role in the metabolism of neurotransmitters, selegiline's selectivity for MAO-B is what makes it effective in the treatment of Parkinson's disease.
Understanding the specific enzyme targeted by selegiline is crucial for healthcare professionals prescribing this medication to manage Parkinson's disease effectively. This knowledge ensures appropriate drug selection and dosing, leading to better patient outcomes.
Option A, Catechol-O-methyltransferase (COMT), is not the correct enzyme inhibited by selegiline. COMT is involved in the metabolism of catecholamines outside the brain.
Option B, Tyrosine hydroxylase (TH), is not the correct enzyme inhibited by selegiline. TH is involved in the synthesis of dopamine and is not the target of selegiline action.
Option D, Monoamine oxidase-A (MAO-A), is not the correct enzyme inhibited by selegiline. While MAO-A also plays a role in the metabolism of neurotransmitters, selegiline's selectivity for MAO-B is what makes it effective in the treatment of Parkinson's disease.
Understanding the specific enzyme targeted by selegiline is crucial for healthcare professionals prescribing this medication to manage Parkinson's disease effectively. This knowledge ensures appropriate drug selection and dosing, leading to better patient outcomes.